Canaan Partners

Canaan Partners

Signal active

Investment Firm

Overview

Canaan is an early stage venture capital firm that invests in entrepreneurs with visionary ideas. With $5B under management, a diversified fund and over 190 exits to date, Canaan has invested in some of the world's leading technology and healthcare companies over the past 30 years. Canaan’s focus areas include fintech, enterprise/cloud, marketplaces, frontier tech, biopharma, digital health, and medtech.

Highlights

Founded

1987

Industry

Venture Capital

Employees

11-50

Investment

793

Lead Investment

265

Exits

167

Stages

Early Stage Venture, Late Stage Venture, Seed, Private Equity

Investor Type

Venture Capital

Location

United States, North America

Contact Information

Social

Profile Resume

Canaan Partners, established in 1987 and headquartered in United States, North America., specializes in Early Stage Venture, Late Stage Venture, Seed, Private Equity investments across Publishing, Content, Online Portals, Financial Services, Finance, FinTech, Personal Finance, Lending, Peer to Peer, Consumer Lending. The organization boasts a portfolio of 789 investments, with an average round size of $32.1M and 167 successful exits. Their recent investments include Associated Content, Lending Club, Norwest Venture Partners, Active Network, CRV. The highest investment round they participated in was $1821.8B. Among their most notable exits are Associated Content and Lending Club. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.

Employees

imagePlace Maha Ibrahim

Maha Ibrahim

General Partner

imagePlace Wende Hutton

Wende Hutton

General Partner

imagePlace Brent Ahrens

Brent Ahrens

General Partner

imagePlace Guy Russo

Guy Russo

General Partner

imagePlace John Balen

John Balen

General Partner

imagePlace Eric Young

Eric Young

Partner and Co-Founder

Investment portfolio

Canaan Partners has made 793 investments. Their most recent investment was on Aug 12, 2024, when Halda Therapeutics raised $126.0M.

Canaan Partners has made 170 diversity investments. Their most recent diversity investment was on Apr 30, 2024, when Qlaris Bio raised $24.0M.

investments

793

Diversity investments

170

Lead investments

265

Number of exits

167

Investments

793

Annouced DateOrganization NameIndustryMoney Raised
Jul 10, 2024
Nagish Nagish
Software11.0M
Jul 16, 2024--150.0M
Jul 24, 2024
Autobahn Therapeutics Autobahn Therapeutics
Biotechnology100.0M
Aug 12, 2024
Halda Therapeutics Halda Therapeutics
Biotechnology126.0M

Exits

167

Funding Timeline

Funding rounds

793

Investors

0

Funds

18

Funding Rounds

793

Canaan Partners has raised 793 rounds. Their latest funding was raised on Aug 12, 2024 from a Series B - Halda Therapeutics round.

Annouced DateTransaction NameNumber of InvestorsMoney RaisedLead Investor
Jul 10, 2024
Series A - Nagish Series A - Nagish
-11.0M-
Jul 16, 2024
Series D - CatalYm Series D - CatalYm
-150.0M-
Jul 24, 2024
Series C - Autobahn Therapeutics Series C - Autobahn Therapeutics
-100.0M-
Aug 12, 2024
Series B - Halda Therapeutics Series B - Halda Therapeutics
-126.0M-

Investors

0

There is no funding round available on this profile

Fund raised

2

Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.

Annouced DateFund NameMoney Raised
May 10, 2013
fund image OTPPLESS
1.0M
May 11, 2013
fund image OTPPLESS
1.0M

Invest in industries

Recent Activity

There is no recent news or activity for this profile.